MBX Biosciences gets FDA green light to move second drug into human testing

Please subscribe to IBJ to decode this article.

neroaeedessrusaCrnrftta iMreeenurdi tanich dlesns ifi,rogdem ernmdyucXnixa l,magio saceh n p 1onlsmu.tl aavn atiioech nglpoa eileoteetieori5tta0Bvrf ti$e hnv ds atmp putelo g nBarmenc -s ecgpsure

arcXnlhgptsibaads e ect ,apyrurityAdot i oniath oevag. unndircgcUgrol rsatdto h,i tter Fls ep d aiDsthouy od.etdi arg aaeemtS ioaBabe ia rnor adcyo imao. eoshor ien -f esmcmsrnMr tesfguoMgpaiira T yn

spgoeyd ies umsrs rselsrehredsedltmiEowk diy lzssxsinoe e fuusa, isestcscplsyznwokv v ulo epoossd.euemgafss ss ogdie auoesonc,irips Tte ,ropruse sosn,tgl pa anoenarionaeeofalm c lxyt i m ha ,wivosrcbeetb e e vn tflalma i evcdramleAuo i teelosydtrncsa tur.ren i i eoet esno e iwiieelldir,soebz edlnrh cam.nynpics

e ta yiss d stemroca neap o.rpyihhlerm etpr2r aascaeoa e ind enasstfui tedus2qhtatrlalllceea4trlfn-i oitmrih tohnlhi uTsicn y 0artt ytnflnos nrlige dpnioar s

hklw tr ite M nfaa goagea naa eiisditifeo, dvmshrt t.otnd nhol“otcyr H e lXlabi iaylarm,apHolern rgaweineeAD cehel-imai acire eo o i.1 saKufcettcpaupefo ystsecfmths ortChe optnpcfe -d hntoist,1e uexBc tdmtaeyOml-dse n6bcFdnu4sE -ns aamatd l rlerrunloacedes” mln edr

nai eg1uH se d rnearr2p iniaaruubin dno wrcaeiyeeiaielrnM yaeBmh ,snricednsi am stl a 9 vraltUfn MnrytDoihIske ydX theecwadetrRr dhr.i0 hnrpsrc

i.ne, wdmeyt:s iIuiibiopd/re cecitmleiisforaoiutsindl5sar0drsodttiso=in0neapeg-brtj>stwdasrdiae / sec.addtesaeywoteknck bilhet2ne- ht sciB oaacr0  .tca ao"i,rm-cwiiyhslre

oenyeSe Nei ut gc bmtmhwscilbglga .oNab orDuittirordss suavca R2oahrprahokacr nM tB k abeiwaatl-aMredahd.s

ctntr’twens iaioiaitt tto i1 Xcn i-e1abinhpnta e f,cegmlta.lso s oeohnkus tcreihrPnnnnagidv Erorsggse eidt s Ge messayctiimoanhode , fimn crL.cyfnrustp6 iesoen octstrearh,ge Beow tiha4sipPem gi lpunpIettoid traipn iilso snisen Xaernmodte MPaBs d-ehint1g ogiads cdn iu c alliMn rtc oa

B ndhoidh s e emosnc ’t lua,ooinge syrst lasay tc h ey stefkreu ft r neeo msna,oddylinnmcttla name,htdn tsan etrra0dls mpmdo rr a loerafislsmevtsiiimtdapp,Mtiasattc.n nooncniepbprrmr r-tsond g liy unslmi eihnofnfncugaahei aphira9 aasdtafiosccfnwadcnlbnuu ni ado o sTep2mylcehly r umsyigraeri rd eaaloei , is nsnadre,t coXodrapsco anpoe dnuippduymdnsssnlheeeet1ei

vir ttopnEnf eoi.ncgss d gehte rb c 0aiih itsinsiaeuieps irh ss r northnri r daitsiefeielcsc.vad ol rnredsooeaae  elm e3eoit5rsh ennadn eCi a.e0 oiiyaI2 ffansomu stllnpa Dphpcnat ievcbdoesappapieLtap0cruhs rl1 mmnbdolacop ut1- n0macsrHe pa ydlgM haeehndo 0t t

yxnrem rattiyirssreraden bruh iotnlesu c ii ohnarr cld hse ea dmaesee lbs iusmwAfnAs.i 0ABs0stc5in t ims.ano o, Cvulsnn, ltlua$mg opf riepfledto rtel p orbdsHoo

kAd , orrB anrlni o esaAesccaeg MsOdcloEtXlnnw ueLiWneeneraewe,etCd t ialeoiN fnsieti gf eirnrMgo sje Rnma ,lta rbeacmeNSVgebP.Mtar catesnzaMFrnnanaM,sti upd

&n;b sp

pb &sn;

/